SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,274,715 | -9.2% | 916,747 | -1.0% | 3.72% | -4.4% |
| Q2 2023 | $27,838,897 | -16.7% | 926,111 | +0.5% | 3.89% | -22.2% |
| Q1 2023 | $33,402,683 | +0.3% | 921,962 | -1.3% | 5.00% | -3.2% |
| Q4 2022 | $33,310,430 | -10.1% | 933,850 | -14.7% | 5.16% | -8.6% |
| Q3 2022 | $37,047,000 | +13.4% | 1,094,443 | -3.1% | 5.65% | +21.7% |
| Q2 2022 | $32,663,000 | -10.1% | 1,129,427 | +0.4% | 4.64% | +18.6% |
| Q1 2022 | $36,341,000 | +18.1% | 1,124,405 | +6.5% | 3.91% | +27.5% |
| Q4 2021 | $30,779,000 | +13.5% | 1,055,530 | +3.8% | 3.07% | +24.6% |
| Q3 2021 | $27,114,000 | -12.0% | 1,016,665 | +1.6% | 2.46% | -11.4% |
| Q2 2021 | $30,820,000 | -4.4% | 1,000,972 | -18.7% | 2.78% | -7.7% |
| Q1 2021 | $32,234,000 | +4.9% | 1,231,228 | +0.8% | 3.01% | +1.2% |
| Q4 2020 | $30,739,000 | +80.4% | 1,221,751 | +49.4% | 2.98% | +46.9% |
| Q3 2020 | $17,037,000 | +4.5% | 817,504 | +19.0% | 2.02% | -4.1% |
| Q2 2020 | $16,309,000 | +57.4% | 686,705 | +19.2% | 2.11% | +15.5% |
| Q1 2020 | $10,362,000 | -37.0% | 576,004 | -16.9% | 1.83% | -16.8% |
| Q4 2019 | $16,446,000 | -25.6% | 693,322 | -13.8% | 2.20% | -31.3% |
| Q3 2019 | $22,105,000 | -19.9% | 804,409 | -3.5% | 3.20% | -13.5% |
| Q2 2019 | $27,580,000 | -6.0% | 833,498 | -0.4% | 3.69% | -13.7% |
| Q1 2019 | $29,325,000 | +17.7% | 836,898 | +11.5% | 4.28% | +5.0% |
| Q4 2018 | $24,924,000 | -29.2% | 750,276 | +7.3% | 4.08% | -4.1% |
| Q3 2018 | $35,216,000 | -15.8% | 699,432 | +0.1% | 4.25% | -22.9% |
| Q2 2018 | $41,816,000 | +3.7% | 698,676 | -20.7% | 5.51% | -9.1% |
| Q1 2018 | $40,339,000 | +34.0% | 880,774 | +16.6% | 6.06% | +29.4% |
| Q4 2017 | $30,111,000 | -0.2% | 755,612 | +0.2% | 4.69% | -3.5% |
| Q3 2017 | $30,172,000 | -7.4% | 754,304 | -0.2% | 4.86% | -14.6% |
| Q2 2017 | $32,590,000 | +39.8% | 756,140 | +1.5% | 5.69% | +27.2% |
| Q1 2017 | $23,307,000 | +43.6% | 744,634 | +15.9% | 4.48% | +37.1% |
| Q4 2016 | $16,225,000 | +2.1% | 642,594 | 0.0% | 3.26% | -0.2% |
| Q3 2016 | $15,891,000 | +21.4% | 642,594 | +0.0% | 3.27% | +11.7% |
| Q2 2016 | $13,089,000 | +52.7% | 642,544 | +14.3% | 2.93% | +43.7% |
| Q1 2016 | $8,573,000 | +25.3% | 562,144 | +10.4% | 2.04% | +26.6% |
| Q4 2015 | $6,844,000 | -4.6% | 509,244 | -0.4% | 1.61% | -4.4% |
| Q3 2015 | $7,173,000 | -70.3% | 511,244 | -64.1% | 1.68% | -36.4% |
| Q2 2015 | $24,180,000 | +194.1% | 1,423,974 | +109.4% | 2.64% | +57.8% |
| Q1 2015 | $8,221,000 | +136.7% | 679,987 | +62.5% | 1.68% | +142.2% |
| Q4 2014 | $3,473,000 | – | 418,400 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |